BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milewska A, Ciejka J, Kaminski K, Karewicz A, Bielska D, Zeglen S, Karolak W, Nowakowska M, Potempa J, Bosch BJ, Pyrc K, Szczubialka K. Novel polymeric inhibitors of HCoV-NL63. Antiviral Res 2013;97:112-21. [PMID: 23201315 DOI: 10.1016/j.antiviral.2012.11.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Mazur-Panasiuk N, Botwina P, Kutaj A, Woszczyna D, Pyrc K. Ozone Treatment Is Insufficient to Inactivate SARS-CoV-2 Surrogate under Field Conditions. Antioxidants (Basel) 2021;10:1480. [PMID: 34573110 DOI: 10.3390/antiox10091480] [Reference Citation Analysis]
2 Jiménez-Arriagada D, Hidalgo AA, Neira V, Neira-Carrillo A, Bucarey SA. Low molecular weight sulfated chitosan efficiently reduces infection capacity of porcine circovirus type 2 (PCV2) in PK15 cells. Virol J 2022;19:52. [PMID: 35331290 DOI: 10.1186/s12985-022-01781-7] [Reference Citation Analysis]
3 Naskalska A, Dabrowska A, Nowak P, Szczepanski A, Jasik K, Milewska A, Ochman M, Zeglen S, Rajfur Z, Pyrc K. Novel coronavirus-like particles targeting cells lining the respiratory tract. PLoS One 2018;13:e0203489. [PMID: 30183777 DOI: 10.1371/journal.pone.0203489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
4 Lin Q, Lim JYC, Xue K, Yew PYM, Owh C, Chee PL, Loh XJ. Sanitizing agents for virus inactivation and disinfection. View 2020;1. [DOI: 10.1002/viw2.16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 15.5] [Reference Citation Analysis]
5 Kalathiya U, Padariya M, Mayordomo M, Lisowska M, Nicholson J, Singh A, Baginski M, Fahraeus R, Carragher N, Ball K, Haas J, Daniels A, Hupp TR, Alfaro JA. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site. J Clin Med 2020;9:E1473. [PMID: 32422996 DOI: 10.3390/jcm9051473] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
6 Milewska A, Falkowski K, Kulczycka M, Bielecka E, Naskalska A, Mak P, Lesner A, Ochman M, Urlik M, Diamandis E, Prassas I, Potempa J, Kantyka T, Pyrc K. Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1. Sci Signal 2020;13:eaba9902. [PMID: 33234691 DOI: 10.1126/scisignal.aba9902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gharpure S, Ankamwar B. Use of nanotechnology in combating coronavirus. 3 Biotech 2021;11:358. [PMID: 34221822 DOI: 10.1007/s13205-021-02905-6] [Reference Citation Analysis]
8 Andrew M, Jayaraman G. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). Carbohydr Res 2021;505:108326. [PMID: 34015720 DOI: 10.1016/j.carres.2021.108326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jonsdottir HR, Dijkman R. Coronaviruses and the human airway: a universal system for virus-host interaction studies. Virol J 2016;13:24. [PMID: 26852031 DOI: 10.1186/s12985-016-0479-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
10 Lachowicz D, Mielczarek P, Wirecka R, Berent K, Karewicz A, Szuwarzyński M, Zapotoczny S. Nanohydrogels Based on Self-Assembly of Cationic Pullulan and Anionic Dextran Derivatives for Efficient Delivery of Piroxicam. Pharmaceutics 2019;11:E622. [PMID: 31766517 DOI: 10.3390/pharmaceutics11120622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Pyrć K, Milewska A, Duran EB, Botwina P, Dabrowska A, Jedrysik M, Benedyk M, Lopes R, Arenas-Pinto A, Badr M, Mellor R, Kalber TL, Fernandez-Reyes D, Schätzlein AG, Uchegbu IF. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray. Sci Rep 2021;11:20012. [PMID: 34625610 DOI: 10.1038/s41598-021-99404-8] [Reference Citation Analysis]
12 Milewska A, Chi Y, Szczepanski A, Barreto-Duran E, Dabrowska A, Botwina P, Obloza M, Liu K, Liu D, Guo X, Ge Y, Li J, Cui L, Ochman M, Urlik M, Rodziewicz-Motowidlo S, Zhu F, Szczubialka K, Nowakowska M, Pyrc K. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. J Virol 2021;95:e01622-20. [PMID: 33219167 DOI: 10.1128/JVI.01622-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
13 Carbajo-Lozoya J, Ma-Lauer Y, Malešević M, Theuerkorn M, Kahlert V, Prell E, von Brunn B, Muth D, Baumert TF, Drosten C, Fischer G, von Brunn A. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Res 2014;184:44-53. [PMID: 24566223 DOI: 10.1016/j.virusres.2014.02.010] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
14 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
15 Das KP, Sharma D, Saha S, Satapathy BK. From outbreak of COVID-19 to launching of vaccination drive: invigorating single-use plastics, mitigation strategies, and way forward. Environ Sci Pollut Res Int 2021;28:55811-45. [PMID: 34480299 DOI: 10.1007/s11356-021-16025-4] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ciejka J, Wolski K, Nowakowska M, Pyrc K, Szczubiałka K. Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses. Mater Sci Eng C Mater Biol Appl 2017;76:735-42. [PMID: 28482585 DOI: 10.1016/j.msec.2017.03.047] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
17 Safarzadeh M, Sadeghi S, Azizi M, Rastegari-Pouyani M, Pouriran R, Haji Molla Hoseini M. Chitin and chitosan as tools to combat COVID-19: A triple approach. Int J Biol Macromol 2021;183:235-44. [PMID: 33930442 DOI: 10.1016/j.ijbiomac.2021.04.157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mi X, Vijayaragavan KS, Heldt CL. Virus adsorption of water-stable quaternized chitosan nanofibers. Carbohydr Res 2014;387:24-9. [PMID: 24561959 DOI: 10.1016/j.carres.2014.01.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
19 Jiang X, Li Z, Young DJ, Liu M, Wu C, Wu YL, Loh XJ. Toward the prevention of coronavirus infection: what role can polymers play? Mater Today Adv 2021;10:100140. [PMID: 33778467 DOI: 10.1016/j.mtadv.2021.100140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X. Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. J Med Chem 2020;63:12256-74. [PMID: 32539378 DOI: 10.1021/acs.jmedchem.0c00502] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 29.5] [Reference Citation Analysis]
21 Shagufta, Ahmad I. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2. Eur J Med Chem 2021;213:113157. [PMID: 33486200 DOI: 10.1016/j.ejmech.2021.113157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
22 Milewska A, Kindler E, Vkovski P, Zeglen S, Ochman M, Thiel V, Rajfur Z, Pyrc K. APOBEC3-mediated restriction of RNA virus replication. Sci Rep 2018;8:5960. [PMID: 29654310 DOI: 10.1038/s41598-018-24448-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 14.5] [Reference Citation Analysis]
23 Milewska A, Kaminski K, Ciejka J, Kosowicz K, Zeglen S, Wojarski J, Nowakowska M, Szczubiałka K, Pyrc K. HTCC: Broad Range Inhibitor of Coronavirus Entry. PLoS One 2016;11:e0156552. [PMID: 27249425 DOI: 10.1371/journal.pone.0156552] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
24 Sharma N, Modak C, Singh PK, Kumar R, Khatri D, Singh SB. Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? Int J Biol Macromol 2021;179:33-44. [PMID: 33607132 DOI: 10.1016/j.ijbiomac.2021.02.090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Milewska A, Nowak P, Owczarek K, Szczepanski A, Zarebski M, Hoang A, Berniak K, Wojarski J, Zeglen S, Baster Z, Rajfur Z, Pyrc K. Entry of Human Coronavirus NL63 into the Cell. J Virol 2018;92:e01933-17. [PMID: 29142129 DOI: 10.1128/JVI.01933-17] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 18.5] [Reference Citation Analysis]
26 Ruiz-Hitzky E, Darder M, Wicklein B, Ruiz-Garcia C, Martín-Sampedro R, Del Real G, Aranda P. Nanotechnology Responses to COVID-19. Adv Healthc Mater 2020;9:e2000979. [PMID: 32885616 DOI: 10.1002/adhm.202000979] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 19.5] [Reference Citation Analysis]
27 Milewska A, Owczarek K, Szczepanski A, Pyrc K. Visualizing Coronavirus Entry into Cells. Methods Mol Biol 2020;2203:241-61. [PMID: 32833217 DOI: 10.1007/978-1-0716-0900-2_18] [Reference Citation Analysis]
28 Favatela MF, Otarola J, Ayala-peña VB, Dolcini G, Perez S, Torres Nicolini A, Alvarez VA, Lassalle VL. Development and Characterization of Antimicrobial Textiles from Chitosan-Based Compounds: Possible Biomaterials Against SARS-CoV-2 Viruses. J Inorg Organomet Polym. [DOI: 10.1007/s10904-021-02192-x] [Reference Citation Analysis]
29 Kuchar E, Miśkiewicz K, Nitsch-Osuch A, Szenborn L. Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections. Adv Exp Med Biol 2015;857:25-38. [PMID: 25786400 DOI: 10.1007/5584_2015_110] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
30 Freitas ED, Moura CF Jr, Kerwald J, Beppu MM. An Overview of Current Knowledge on the Properties, Synthesis and Applications of Quaternary Chitosan Derivatives. Polymers (Basel) 2020;12:E2878. [PMID: 33266285 DOI: 10.3390/polym12122878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Ciejka J, Botwina P, Nowakowska M, Szczubiałka K, Pyrc K. Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus. PLoS One 2019;14:e0214646. [PMID: 30921418 DOI: 10.1371/journal.pone.0214646] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
32 Chen X, Han W, Wang G, Zhao X. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines. Int J Biol Macromol 2020;164:331-43. [PMID: 32679328 DOI: 10.1016/j.ijbiomac.2020.07.106] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
33 Zhou J, Krishnan N, Jiang Y, Fang RH, Zhang L. Nanotechnology for virus treatment. Nano Today 2021;36:101031. [PMID: 33519948 DOI: 10.1016/j.nantod.2020.101031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
34 Botwina P, Obłoza M, Szczepański A, Szczubiałka K, Nowakowska M, Pyrć K. In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate). Viruses 2020;12:E926. [PMID: 32842540 DOI: 10.3390/v12090926] [Reference Citation Analysis]
35 Umar Y, Al-Batty S, Rahman H, Ashwaq O, Sarief A, Sadique Z, Sreekumar PA, Haque SKM. Polymeric Materials as Potential Inhibitors Against SARS-CoV-2. J Polym Environ 2021;:1-20. [PMID: 34518763 DOI: 10.1007/s10924-021-02272-6] [Reference Citation Analysis]